Jianzhong Wang | Prevention and control of infectious diseases | Best Researcher Award

Assoc Prof Dr. Jianzhong Wang | Prevention and control of infectious diseases | Best Researcher AwardĀ 

Assoc Prof Dr Jianzhong Wang Jilin Agricultural University China

Jianzhong Wang, an associate professor at Jilin Agricultural University, specializes in designing novel vaccines using genetic engineering. His research focuses on canarypox virus-based vaccine candidates and bacterium-like particles to enhance immune responses in veterinary medicine. With numerous publications and ongoing projects, he aims to address critical health issues in animal diseases and improve vaccination strategies.

profile:

Scopus

šŸŽ“ Academic and Professional Background :

I specialize in the design of novel vaccines using genetic engineering techniques and exploring their immune mechanisms. My educational journey includes a B.Sc. in Animal Science, an M.Sc. in Preventive Veterinary Medicine, and a Ph.D. in the same field. I’ve held various academic positions, culminating in my current role as an associate professor.

šŸ”¬ Research and Innovations:

Completed/Ongoing Research Projects: Developing canarypox virus-based vaccine candidates using CRISPR/Cas9.Citation Index: [Link]Consultancy/Industry Projects: [Details]Books Published (ISBN): [Titles]Patents Published/Under Process: [Details]Journals Published: A single dose of an ALVAC vector-based RABV virus-like particle candidate vaccine induces a potent immune response in mice, cats, and dogs. Emerg Microbes Infect. 2024 Sep 19:2406280.Editorial Appointments: [Details]Collaborations: [Details]Professional Memberships: [Details]Areas of Research: Veterinary Medicine

šŸŒŸ Contributions :

My contributions involve designing studies that lead to significant advancements in vaccine development. I’ve pioneered the use of bacterium-like particles in vaccine technology, which enhances immune responses. My work has been instrumental in addressing critical health issues in veterinary medicine.

Publication:šŸ“

  • Title: Oral vaccination with a recombinant Lactobacillus plantarum expressing the Eimeria tenella rhoptry neck 2 protein elicits protective immunity in broiler chickens infected with Eimeria tenella
    Authors: Zhang, T., Qu, H., Zheng, W., Zhang, J., Wang, N.
    Year: 2024
    Journal: Parasites and Vectors
    Volume: 17
    Issue: 1
    Article Number: 277

 

  • Title: Gut microbiota-derived LCA mediates the protective effect of PEDV infection in piglets
    Authors: Xing, J.-H., Niu, T.-M., Zou, B.-S., Yang, W.-T., Wang, C.-F.
    Year: 2024
    Journal: Microbiome
    Volume: 12
    Issue: 1
    Article Number: 20

 

  • Title: CRISPR/Cas13a-based genome editing for establishing the detection method of H9N2 subtype avian influenza virus
    Authors: Chen, S.-S., Yang, Y.-L., Wang, H.-Y., Yang, W.-T., Wang, C.-F.
    Year: 2024
    Journal: Poultry Science
    Volume: 103
    Issue: 10
    Article Number: 104068

 

  • Title: ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota
    Authors: Cheng, M., Xu, B., Sun, Y., Wang, C., Cao, X.
    Year: 2024
    Journal: mBio
    Volume: 15
    Issue: 9
    Article Number: e0204324

 

  • Title: AhR ligands from LGG metabolites promote piglet intestinal ILC3 activation and IL-22 secretion to inhibit PEDV infection
    Authors: Wang, J., Zhao, Y., Cui, T., Wang, C., Cao, X.
    Year: 2024
    Journal: Journal of Virology
    Volume: 98
    Issue: 8

 

  • Title: Antibacterial Plasma Coating with Aggregation-Induced Emission Photosensitizers to Prevent Surgical Site Infections
    Authors: Sahu, R., Ninan, N., Nguyen, N.H., Truong, V.K., Tang, Y.
    Year: 2024
    Journal: Advanced Materials Interfaces
    Volume: 11
    Issue: 15
    Article Number: 2400053

Conclusion

In conclusion, Jianzhong Wang’s innovative research in vaccine development leverages advanced genetic engineering techniques to enhance immune responses in veterinary medicine. His contributions not only advance scientific understanding but also address pressing health challenges in animal populations. With a strong publication record and ongoing projects, his work exemplifies a commitment to improving vaccine efficacy and animal health.

Haseeb Sattar | Clinical Medicine | Best Faculty Award

Assoc Prof Dr. Haseeb Sattar | Clinical MedicineĀ  | Best Faculty Award

Assoc Prof Dr Haseeb Sattar Urban Vocational College of Sichuan Chengdu China

Dr. Haseeb Sattar is a seasoned medical professional with extensive experience in clinical pharmacotherapy and internal medicine. He holds a PhD in Clinical Pharmacology from Huazhong University of Science and Technology, China, and has served as an Assistant Professor at several prestigious universities in China, teaching clinical subjects to international MBBS students. Dr. Sattar has a strong background in research, with numerous publications in leading medical journals. His career is distinguished by his commitment to medical education, research, and patient care, making him a valuable asset to any academic or clinical institution.

Publication profile

Scopus

Scholar

šŸŽ“ Education

PhD/DM in Clinical Pharmacology-Clinical Pharmacy – Tongji Medical College of Huazhong University of Science and Technology, China. Dates: September 2014 ā€“ June 2017. PG-Dip in Internal Medicine – University of Edinburgh, UK Dates: September 2018 ā€“ August 2020. MPhil in Medical Microbiology – Quaid-i-Azam University, Islamabad, Pakistan Dates: January 2012 ā€“ 2014. Doctor of Pharmacy (PharmD) – Riphah International University, Islamabad, Pakistan Dates: September 2005 ā€“ August 2010. Higher Secondary School Certificate (HSSC) – Federal Board of Intermediate & Secondary Education, Islamabad, Pakistan. Dates: August 2002 ā€“ August 2004. Diploma in Computer Hardware – Super Tech Institute of Computer Sciences Dates: May 2002 ā€“ August 2002. Secondary School Certificate (SSC) – Federal Board of Intermediate & Secondary Education, Islamabad, Pakistan Dates: March 2000 ā€“ March 2002

šŸ‘Øā€šŸ« Professional Experience

Assistant Professor of Medicine – Chengdu University of TCM, Chengdu, China Dates: September 2019 ā€“ Present Responsibilities: Teaching clinical subjects to foreign MBBS students. Assistant Professor of Medicine – Hubei University of Traditional Chinese Medicine, Wuhan, China Dates: September 2017 ā€“ July 2019 Responsibilities: Teaching clinical subjects to foreign MBBS students. Lecturer (Part-Time) – Hubei University of Nationality, Enshi, China Dates: July 2016 ā€“ July 2017. Responsibilities: Teaching internal medicine, diagnostics, pharmacology, preventive medicine, and infectious diseases. Lecturer of Clinical Pharmacotherapeutics and Clinical Practices – University of Lahore, Islamabad Campus Dates: September 2010 ā€“ September 2014 Responsibilities: Taking lectures, hospital ward rounds.

šŸ… Certifications

American Board Certification in Pharmacotherapy (BCPS), USA. American Board-Certified Cardiology Specialist (BCCP). Certification in Toxicology, Harvard Medical University, USA. Certification in Endocrine Emergencies, Harvard Medical University, USA. Certification in COPD Management, University of Pennsylvania School of Medicine, USA

šŸ“ Research Publications

Sattar, Haseeb, et al. “Role of glucuronidation pathway in quetiapine metabolism: An in vivo drugā€“drug interaction study between quetiapine and probenecid.” Saudi Journal of Medicine & Medical Sciences, 2020. Nie Q, Sattar H, et al. “An intramural left ventricular fistula caused by left ventriculography.” World Journal of Emergency Medicine, 2022. Luo Y, Jiang Q, Zhu Z, Sattar H, et al. “Phosphoproteomics and proteomics reveal metabolism as a key node in LPS-induced acute inflammation in RAW264. 7.” Inflammation, 2020.

šŸ† Achievements

Recipient of the Chinese Government Scholarship. Multiple scholarships during university (Mumtaz Scholarships)

Evaluation for Best Faculty Award šŸ†

Strengths for the Award:

Extensive Clinical and Academic Experience: Dr. Haseeb Sattar has over a decade of experience in clinical pharmacotherapy and internal medicine, with a strong foundation in both practical and theoretical aspects of the field. His roles in various academic institutions, particularly in teaching clinical subjects to MBBS students, demonstrate his commitment to education and student development. Diverse Educational Background: Dr. Sattar’s qualifications, including a Doctor of Pharmacy (PharmD), MPhil in Medical Microbiology, and PhD/DM in Clinical Pharmacology, provide him with a broad and in-depth understanding of medicine. His postgraduate diploma in Internal Medicine from the University of Edinburgh further solidifies his expertise. Research Accomplishments: With numerous publications in reputable journals, Dr. Sattar has contributed significantly to medical research. His work spans various topics, including pharmacotherapy, clinical pharmacy, and internal medicine, reflecting his active engagement in advancing medical knowledge. International Exposure: Dr. Sattar’s teaching and research experiences across Pakistan and China, coupled with certifications from prestigious institutions in the USA, highlight his global perspective and adaptability in different educational and healthcare environments. Recognition and Awards: Dr. Sattar has been the recipient of multiple scholarships, including the prestigious Chinese Government Scholarship, which underscores his academic excellence and recognition by international bodies.

Areas for Improvement:

Focused Research Themes: While Dr. Sattar has published extensively, focusing on a more specific research theme or developing a specialized niche could enhance his recognition in a particular area of medicine. Increased Collaboration: Engaging in more collaborative research with other international institutions and experts could further elevate his profile and contribute to broader scientific advancements. Leadership Roles: Taking on more leadership roles in academic or research institutions could showcase his ability to influence and guide future research directions and academic programs.

Publication top notes

  • Reactive Oxygen Speciesā€Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer
    • Journal: Oxidative Medicine and Cellular Longevity
    • Year: 2018
    • DOI: 10.1155/2018/5801209
    • Contributors: H. Gu, T. Huang, Y. Shen, Y. Liu, F. Zhou, Y. Jin, H. Sattar, Y. Wei
    • Citations: 64

 

  • Co-existence of blaNDM-1 and blaKPC-2 in Clinical Isolates of Klebsiella pneumoniae from Pakistan
    • Journal: Journal of Chemotherapy
    • Year: 2016
    • Volume: 28(4), 346-349
    • Contributors: H. Sattar, M. Toleman, F. Nahid, R. Zahra
    • Citations: 35

 

  • The Prognostic Value of Long Noncoding RNAs in Prostate Cancer: A Systematic Review and Meta-Analysis
    • Journal: Oncotarget
    • Year: 2017
    • Volume: 8(34), 57755
    • Contributors: W. Ma, X. Chen, L. Ding, J. Ma, W. Jing, T. Lan, H. Sattar, Y. Wei, F. Zhou
    • Citations: 24

 

  • Natural Killer Cell Immunotherapy Against Multiple Myeloma: Progress and Possibilities
    • Journal: Journal of Leukocyte Biology
    • Year: 2018
    • Volume: 103(5), 821-828
    • Contributors: P. Liu, Y. Jin, H. Sattar, H. Liu, W. Xie, F. Zhou
    • Citations: 18

 

Conclusion:

Dr. Haseeb Sattar’s extensive clinical experience, robust academic background, and significant research contributions make him a strong candidate for the Best Faculty Award. His diverse expertise and international exposure, combined with his dedication to education and research, position him as an exemplary figure in the field of medicine. With a focus on further specialization and increased collaborative efforts, Dr. Sattar’s impact on the medical community is likely to grow, making him well-deserving of this recognition.

Hao Chi | clinical medicine | Young Scientist Award

Ā Mr. Hao Chi |Electoral Studies | Best Researcher AwardĀ 

Dr. Hao Chi, MD, is affiliated with the Clinical Medical College at Southwest Medical University in Luzhou, China. With an H-index of 21 and 1069 citations, Dr. Chi is a prolific researcher focusing on programmed cell death, therapy resistance in cancers, immune microenvironment, advanced data analysis, and exosomal dynamics in tumor ecology. He has contributed to numerous high-impact journals and serves on editorial boards and as a guest editor for several scientific publications. Dr. Chi’s expertise in utilizing cutting-edge sequencing technologies and bioinformatics positions him at the forefront of cancer research and personalized medicine.

Profile

Scholar

Education šŸŽ“

MD, Clinical Medicine
Southwest Medical University, Luzhou 646000, China

Research Experiences and Interests šŸ”¬

Programmed Cell Death and Tumor Prognosis Investigating the mechanisms of programmed cell death and their relevance to tumor prognosis.
Publications: Frontiers in Genetics 2022, Cells 2022, Frontiers in Molecular Biosciences 2023. Molecular Mechanisms of Therapy Resistance of Cancers Studying genetic, epigenetic, and immune system factors leading to cancer cell resistance to treatments. Publications: Journal of Medical Virology 2023, Frontiers in Immunology 2023. Immune Microenvironment and Cancer Prognostication Analyzing the tumor immune microenvironment to identify prognostic markers. Publications: Frontiers in Immunology 2022, 2023. Advanced Data Analysis in Disease Applying machine learning to diagnose and prognose diseases using multi-omics data. Publications: Frontiers in Endocrinology 2022, Tumour Virus Research 2023, Frontiers in Oncology 2023. Single-Cell and High-Throughput Sequencing Technologies Utilizing sequencing technologies to explore tumor microenvironment and therapeutic responses. Publications: Frontiers in Immunology 2023, Frontiers in Molecular Biosciences 2023, Frontiers in Pharmacology 2023. Exosomal Dynamics in Tumor Ecology Investigating the role of exosomes in cancer progression and their therapeutic potential. Publications: Journal of Oncology 2022, Frontiers in Immunology 2022, 2023.

Skills šŸ› ļø

  1. Data Analysis
    • Proficient in R language and bioinformatics for processing and visualizing patient data from TCGA, GEO, ICGC, and CGGA.
    • Integrating high-throughput sequencing data, single-cell sequencing data, and spatial transcriptome data.
  2. Cellular and Molecular Biology
    • Designing and performing cellular phenotyping experiments.
    • Cell culture and transfection.
    • Techniques: PCR, WB, IHC, transfection, MTT, Edu assay, CCK8, transwell assay, wound healing assay, colony formation assay, flow cytometry.
  3. Animal Experiments
    • In vivo experiments, including subcutaneous tumor formation, tumor tissue collection, and physiological monitoring.

Academic Positions šŸ§‘ā€šŸ«

  1. Editorial Board Member
    • Discover Immunity (2024)
    • BMC Cancer (2023-present)
    • Discover Oncology (2023-present)
    • iMeta (2023-present)
  2. Guest Editor
    • Discover Oncology (2024)
    • Current Protein & Peptide Science (2024)
    • Current Genomics (2024)
    • Frontiers in Immunology (2024)
    • Current Cancer Drug Targets (2024)
    • Current Gene Therapy (2024)
    • Journal of Visualized Experiments (2023)
  3. Editorial Review Board Member
    • Oncology Research (2024)
    • Technology in Cancer Research & Treatment (2024.02-present)
    • Cancer Control (2024.02-present)
  4. Reviewer
    Journals including International Journal of Surgery, European Journal of Internal Medicine, Cancer Letters, Cell Communication and Signaling, Computers in Biology and Medicine, iScience, Inflammation Research, Environmental Toxicology, Scientific Reports, Heliyon, Frontiers in Immunology, Aging, Discover Oncology, Journal of Gene Medicine, BMC Bioinformatics, BMC Medical Genomics, BMC Cancer, BMC Pulmonary Medicine, Functional & Integrative Genomics, Archives of Dermatological Research, Journal of Orthopaedic Surgery and Research, Molecular and Cellular Biochemistry, PLOS ONE, Current Pharmaceutical Design, Open Life Sciences, JOVE, Medicine, Frontiers in Pharmacology, Frontiers in Genetics, Frontiers in Oncology, Frontiers in Surgery, Frontiers in Aging Neuroscience, Frontiers in Neuroscience, Frontiers in Molecular Biosciences, Frontiers in Public Health, Gene, Journal of Cancer, Acta Oncologica, Journal of the COPD Foundation, Cell Biology International, Oncology Research, Artificial Intelligence in Medicine, Expert Opinion on Drug Safety, Pharmaceutical Biology, Experimental Cell Research, Current Drug Targets, Journal of Inflammation Research, Journal of Stroke and Cerebrovascular Diseases, iMeta, Turkish Journal of Gastroenterology, Pharmaceutical Biology, Journal of Pain Research, World Journal of Urology, International Journal of Molecular Medicine, Diabetes, Obesity and Metabolism, Annals of Medicine, Technology in Cancer Research & Treatment, Acta Psychologica, OncoTargets and Therapy.

Oral Presentations šŸŽ¤

Invited Speaker, “Guidance on University Students’ Innovation and Entrepreneurship Projects,” Scientific Research Department of Southwest Medical University, Luzhou, China, March 2023. Workshop Conductor, “Integrating High-Throughput Sequencing Data with Machine Learning,” Sino-German Laboratory at the Affiliated Hospital of Southwest Medical University, Luzhou, China, May 2023. Presenter, Summer Research Symposium, General Hospital of the People’s Liberation Army, “Integration of Modern Medicine with Acupuncture and Moxibustion Research,” Beijing, China, May 2023. Featured Speaker, Fall Research Symposium, Beijing University of Chinese Medicine, “Advances in Breast Cancer by Single Cell Sequencing,” Beijing, China, July 2023. Keynote Speaker, “Single-Cell Sequencing: Implications for Precision Medicine,” The Affiliated Hospital of Southwest Medical University, Luzhou, China, June 2023. Invited Speaker, “Multi-Omics and Machine Learning: A New Era in Disease Understanding,” Chongqing Biomarkers Committee, Chongqing, China, October 2023. Invited Speaker, “Macao University of Science and Technology (MUST) Faculty of Medicine Chinese Medicine Master Teachers Forum Meeting,” Macau University of Science and Technology, Macau, China, October 2023.

Book Publications šŸ“š

  • Deputy Editor: Clinical Research on Chinese Medicine Treatment for Diabetes Mellitus, Shanghai Jiao Tong University Press, Shanghai, China, 2023.

Publications Top Notes šŸ“

  • Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
    • Authors: H. Chi, X. Xie, Y. Yan, G. Peng, D.F. Strohmer, G. Lai, S. Zhao, Z. Xia, G. Tian
    • Journal: Frontiers in Immunology, 2022
    • Citations: 79

 

  • A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration
    • Authors: H. Chi, P. Jiang, K. Xu, Y. Zhao, B. Song, G. Peng, B. He, X. Liu, Z. Xia, G. Tian
    • Journal: Frontiers in Genetics, 2022
    • Citations: 79

 

  • T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
    • Authors: H. Chi, S. Zhao, J. Yang, X. Gao, G. Peng, J. Zhang, X. Xie, G. Song, K. Xu
    • Journal: Frontiers in Immunology, 2023
    • Citations: 63

 

  • Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinsonā€™s disease
    • Authors: S. Zhao, H. Chi, Q. Yang, S. Chen, C. Wu, G. Lai, K. Xu, K. Su, H. Luo, G. Peng
    • Journal: Frontiers in Immunology, 2023
    • Citations: 54

 

  • Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity
    • Authors: H. Chi, J. Yang, G. Peng, J. Zhang, G. Song, X. Xie, Z. Xia, J. Liu, G. Tian
    • Journal: Frontiers in Immunology, 2023
    • Citations: 5

 

  • Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer
    • Authors: S. Zhao, X. Zhang, F. Gao, H. Chi, J. Zhang, Z. Xia, C. Cheng, J. Liu
    • Journal: Frontiers in Endocrinology, 2023
    • Citations: 52

 

  • Cuprotosis programmed-cell-death-related lncRNA signature predicts prognosis and immune landscape in PAAD patients
    • Authors: H. Chi, G. Peng, R. Wang, F. Yang, X. Xie, J. Zhang, K. Xu, T. Gu, X. Yang
    • Journal: Cells, 2022
    • Citations: 47

 

  • IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
    • Authors: Y. Zhao, K. Wei, H. Chi, Z. Xia, X. Li
    • Journal: Frontiers in Immunology, 2022
    • Citations: 42

 

  • Exosomes: A potential tool for immunotherapy of ovarian cancer
    • Authors: X. Gong, H. Chi, D.F. Strohmer, A.T. Teichmann, Z. Xia, Q. Wang
    • Journal: Frontiers in Immunology, 2023
    • Citations: 40

 

  • A bioinformatics-based analysis of an anoikis-related gene signature predicts the prognosis of patients with low-grade gliomas
    • Authors: S. Zhao, H. Chi, W. Ji, Q. He, G. Lai, G. Peng, X. Zhao, C. Cheng
    • Journal: Brain Sciences, 2022
    • Citations: 40

 

Divya Kumar | Clinical |Best Researcher Award

Dr. ā€ŒDivya Kumar |Clinical| Best Researcher Award

Dr at McLean Hospital, United States

Divya Kumar is a dedicated clinical psychologist with a focus on affective disorders and behavioral interventions. Currently completing a Post-Doctoral Fellowship at McLean Hospital/Harvard Medical School, Divya’s research and clinical experiences span various settings, including academic institutions and healthcare facilities. With expertise in positive affect dysregulation and depression treatment, Divya has authored multiple peer-reviewed publications and presented at national conferences. Their commitment to teaching and mentorship is evident through roles as an instructor and teaching assistant. Divya’s comprehensive training and contributions to the field make them a valuable asset in clinical research and practice.

Profile

 

šŸ“šEducationĀ 

McLean Hospital/Harvard Medical School Belmont, MA Post-Doctoral Fellowship, Clinical Psychology July 2023 ā€“ Present Pre-Doctoral Intern, Clinical Psychology July 2022 – June 2023 Southern Methodist University Dallas, TX Doctoral Candidate, Clinical Psychology July 2023 Advisor: Alicia E. Meuret, Ph.D. Dissertation: A randomized controlled trial of brief behavioral activation plus savoring for positive emotion dysregulation in university students Master of Arts, Clinical Psychology August 2020 Advisor: Alicia E. Meuret, Ph.D. Thesis: Walking on the bright side: Associations between depression, affect, and gait Washington University in St. Louis St. Louis, MO Bachelor of Arts, Philosophy-Neuroscience-Psychology December 2014

Honours and awards šŸ†

šŸ† 2024 Career Development Leadership Program Anxiety and Depression Association of AmericašŸŽ“ 2017 ā€“ 2023 University Ph.D. Fellowship Award Southern Methodist UniversityšŸ… 2022 Virginia Roswell Student Dissertation Award Association of Behavioral and Cognitive TherapiesšŸ”¬ 2019 President Partnerā€™s Grant Southern Methodist University (CO-I: Alicia Meuret)šŸŽ–ļø 2019 Honorable Mention for Graduate Research Fellowship Program National Science FoundationšŸ„‡ 2019 Graduate Student Research Day Award Dedman College, Southern Methodist University

manuscripts in peer reviewed journals

Kumar, D., Corner, S., Kim, R., Meuret, A. (2024). A randomized controlled trial of brief behavioral activation plus savoring for positive affect dysregulation in university students. Behaviour Research and Therapy, 104525. Alvi, T., Kumar, D., Tabak, B. (2022). Social anxiety and behavioral assessments of social cognition: A systematic review. Journal of Affective Disorders, 311, 17-30. Kumar, D., Villarreal, D. J., Meuret, A. E. (2021). Walking on the bright side: Relations between depression, affect, and gait. PLoS one, 16(12), e0260893. Kumar, D., Tully, L.M., Iosif, A.M., Nye, K.E., Zakskorn, L.N., Zia, A., Niendam, T.A. (2018). A mobile health platform for clinical monitoring in early psychosis: implementation in community-based outpatient early psychosis care. Journal of Medical Internet Research Mental Health, 5(1): e15. Niendam, T.A., Tully, L.M., Iosif, A.M., Kumar, D., Burch, K., Denton, J., Zakskorn, L., Fedechko, T., Pierce, K. (2018). Enhancing early psychosis treatment using smartphone technology Part I: Feasibility and validity. Journal of Psychiatric Research, 96, 239-246.

Clinical Experience šŸ„

Behavioral Health Partial Hospitalization Program, McLean Hospital Belmont, MA Psychology Intern | July 2022 ā€“ July 2023As a psychology intern, I provided brief intervention for patients in the partial hospital program, drawing skills from CBT, ACT, and DBT. Additionally, I led and co-led skills-based groups on empirically supported therapies weekly. Moreover, I provided individual ERP therapy through the McLean Obsessive Compulsive Disorder Institute as part of a 3-month rotation and individual psychotherapy through the McLean OnTrack Early Psychosis Clinic. šŸ©ŗTreatment for Affective Dimensions Study, Dallas, TX Study Therapist | August 2018 ā€“ June 2022In this role, I provided psychotherapy related to increasing positive affect through behavioral activation, positive cognitive strategies, and mindfulness practices. I also offered psychotherapy related to decreasing negative affect through inhibitory learning model exposures, cognitive restructuring, and respiratory biofeedback. Furthermore, I conducted structured diagnostic evaluations (SCID-5) for study intake. šŸ§ SMU Psychology Clinic, Dallas, TX
Advanced Practicum Student | June 2021 ā€“ June 2022At the SMU Psychology Clinic, I provided structured diagnostic interviews and individual psychotherapy via telehealth to adult clients in Dallas using empirically-supported treatments such as CBT, ACT, and CPT. Additionally, I conducted symptom-based evaluations of trauma in collaboration with the Human Rights Initiative of Dallas for individuals seeking legal citizenship through the U-VISA program and Violence Against Women Act. šŸ’¬Behavioral Activation plus Savoring Study, Dallas, TX
Principal Investigator/Study Therapist | July 2021 ā€“ June 2022In this position, I served as the principal study therapist, providing two sessions of brief behavioral activation plus savoring therapy for university students with low positive affect. I also created therapy manuals and homework assignments for a randomized controlled trial and trained master’s-level graduate students in delivering manualized treatment. šŸ“šVeteranā€™s Association North Texas Health Care System, Dallas, TX Practicum Student | August 2020 ā€“ June 2021During my time here, I provided individual psychotherapy via Telehealth utilizing Acceptance and Commitment Therapy to Veterans for symptoms relating to depression, anxiety, and physical health. Additionally, I engaged in individual supervision to enhance competency in providing gender-affirming care. šŸ”

Additional Clinical Training Experience and Workshops šŸŽ“

In addition to my clinical experience, I’ve undertaken various training sessions and workshops to enhance my skills and knowledge in the field of psychology:

Positive Affect Treatment Training šŸŒŸInhibitory Exposure (Negative Affect Treatment Training) šŸ›‘Psychological Assessment Series Training: Millon Multiaxial Clinical Inventory šŸ“Psychological Assessment Series Training: Personality Assessment Inventory šŸ§ Comprehensive Behavioral Intervention for Tics šŸ’­Treatment for Affective Disorders šŸŒˆCapnometry-Assisted Respiratory Training šŸ’ØCognitive Processing Therapy for Post-Traumatic Stress Disorder šŸ§ Integrated Psychosis Assessment Training šŸ”„Structured Clinical Interview for DSM-5 (SCID-5) Training šŸ’¬Training in Applied Behavior Analysis for Children with Autism šŸ§©

 

Publications Top Notes šŸ“

 

  1. Enhancing Early Psychosis Treatment Using Smartphone Technology: A Longitudinal Feasibility and Validity Study
    • Journal: Journal of Psychiatric Research, 2018
    • Citations: 117
    • Authors: T.A. Niendam, L.M. Tully, A.M. Iosif, D. Kumar, K.E. Nye, J.C. Denton, …

 

  1. A Mobile Health Platform for Clinical Monitoring in Early Psychosis: Implementation in Community-based Outpatient Early Psychosis Care
    • Journal: JMIR Mental Health, 2018
    • Citations: 75
    • Authors: D. Kumar, L.M. Tully, A.M. Iosif, L.N. Zakskorn, K.E. Nye, A. Zia, T.A. Niendam

 

  1. Social Anxiety and Behavioral Assessments of Social Cognition: A Systematic Review
    • Journal: Journal of Affective Disorders, 2022
    • Citations: 23
    • Authors: T. Alvi, D. Kumar, B.A. Tabak

 

  1. Walking on the Bright Side: Associations Between Affect, Depression, and Gait
    • Journal: PLOS One, 2021
    • Citations: 7
    • Authors: D. Kumar, D.J. Villarreal, A.E. Meuret

 

  1. A Randomized Controlled Trial of Brief Behavioral Activation Plus Savoring for Positive Affect Dysregulation in University Students
    • Journal: Behaviour Research and Therapy, 2024
    • Authors: D. Kumar, S. Corner, R. Kim, A. Meuret